forecast
Early Modality Lead Compounds Advantage
Moderna's head start in RNA drugs gives it an advantage in pursuing the low-hanging fruit of this modality, though many competitors will follow.
forecastpending
Speaker
Jason KellyEvidence Quote
“they're ahead of other people and pursuing all the other low-hanging fruit for that.”
Created: 11/15/2026, 7:57:10 PM
Your notes
Loading notes...